Recent Finacing
Recent Raise
FortuneRock discovers, develops and commercializes gene-based recombinant protein drugs using long-acting protein platforms and a high-efficacy yeast expression system, producing kilogram-scale proteins and running preclinical/clinical trials in China.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor